Search research articles
Contact Us
Filters
Showing results (141-150 of 174) with videos related to
Page
of 18
Sort By:
Nature Communications
|
March 19, 2022
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
Ezra Y Rosen, Helen H Won, Youyun Zheng, et al.
Cancer Discovery
|
October 2, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, et al.
Cancer Discovery
|
January 12, 2020
Characteristics and Outcome of <i>AKT1</i> <sup>E17K</sup>-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry
Lillian M Smyth, Qin Zhou, Bastien Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Nature
|
July 12, 2019
Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Cancer Discovery
|
December 17, 2017
Accelerating Discovery of Functional Mutant Alleles in Cancer
Matthew T Chang, Tripti Shrestha Bhattarai, Alison M Schram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
Maeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
Nature
|
December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
The New England Journal of Medicine
|
February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors
Eric Wang, Xiaoli Mi, Meghan C Thompson, et al.
Journal of the National Cancer Institute
|
March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
Maeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 174) with videos related to
Sort By:
Page
of 18
Nature Communications
|
March 19, 2022
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
Ezra Y Rosen, Helen H Won, Youyun Zheng, et al.
Cancer Discovery
|
October 2, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, et al.
Cancer Discovery
|
January 12, 2020
Characteristics and Outcome of <i>AKT1</i> <sup>E17K</sup>-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry
Lillian M Smyth, Qin Zhou, Bastien Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Nature
|
July 12, 2019
Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Cancer Discovery
|
December 17, 2017
Accelerating Discovery of Functional Mutant Alleles in Cancer
Matthew T Chang, Tripti Shrestha Bhattarai, Alison M Schram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
Maeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
Nature
|
December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
The New England Journal of Medicine
|
February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors
Eric Wang, Xiaoli Mi, Meghan C Thompson, et al.
Journal of the National Cancer Institute
|
March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
Maeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Page
of 18